2,064
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting

, , , , , , , , & show all
Pages 4489-4499 | Received 28 Apr 2021, Accepted 08 Jul 2021, Published online: 26 Jul 2021

References

  • Kisala PA, Victorson D, Pace N, et al. Measuring psychological trauma after spinal cord injury: development and psychometric characteristics of the SCI-QOL Psychological Trauma item bank and short form. J Spinal Cord Med. 2015 May;38(3):326–334.
  • Lim SW, Shiue YL, Ho CH, et al. Anxiety and depression in patients with traumatic spinal cord injury: a nationwide population-based cohort study. PLoS One. 2017;12(1):e0169623.
  • McKinley WO, Jackson AB, Cardenas DD, et al. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil. 1999 Nov;80(11):1402–1410.
  • Benevento BT, Sipski ML. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys Ther. 2002 Jun;82(6):601–612.
  • Lynch AC, Antony A, Dobbs BR, et al. Bowel dysfunction following spinal cord injury. Spinal Cord. 2001 Apr;39(4):193–203.
  • Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma. 2004 Oct;21(10):1371–1383.
  • Simpson LA, Eng JJ, Hsieh JT, et al. Spinal cord injury rehabilitation evidence scire research, t. the health and life priorities of individuals with spinal cord injury: a systematic review. J Neurotrauma. 2012 May 20;29(8):1548–1555.
  • Sezer N, Akkus S, Ugurlu FG. Chronic complications of spinal cord injury. World J Orthop. 2015 Jan 18;6(1):24–33.
  • Stoffel JT, Van Der Aa F, Wittmann D, et al. Neurogenic bowel management for the adult spinal cord injury patient. World J Urol. 2018 Oct;36(10):1587–1592.
  • Benarroch EE. Autonomic nervous system and neuroimmune interactions: new insights and clinical implications. Neurology. 2019 Feb 19;92(8):377–385.
  • Kigerl KA, Zane K, Adams K, et al. The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury. Exp Neurol. 2020 Jan;323:113085.
  • Jogia T, Ruitenberg MJ. Traumatic spinal cord injury and the gut microbiota: current insights and future challenges. Front Immunol. 2020;11:704.
  • Kigerl KA, Mostacada K, Popovich PG. Gut microbiota are disease-modifying factors after traumatic spinal cord injury. Neurotherapeutics. 2018 Jan;15(1):60–67.
  • Zhang C, Zhang W, Zhang J, et al. Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury. J Transl Med. 2018 Dec 13;16(1):353.
  • Krassioukov A, Eng JJ, Claxton G, et al. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010 Oct;48(10):718–733.
  • Kigerl KA, Hall JC, Wang L, et al. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016 Nov 14;213(12):2603–2620.
  • O’Connor G, Jeffrey E, Madorma D, et al. Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model. J Neurotrauma. 2018 Sep 15;35(18):2159–2166.
  • Wallace DJ, Sayre NL, Patterson TT, et al. Spinal cord injury and the human microbiome: beyond the brain-gut axis. Neurosurg Focus. 2019 Mar 1;46(3):E11.
  • Gungor B, Adiguzel E, Gursel I, et al. Intestinal microbiota in patients with spinal cord injury. PLoS One. 2016;11(1):e0145878.
  • Kirshblum S, Waring W. 3rd. updates for the international standards for neurological classification of spinal cord injury. Phys Med Rehabil Clin N Am. 2014 Aug;25(3):505–517. . vii.
  • Krogh K, Christensen P, Sabroe S, et al. Neurogenic bowel dysfunction score. Spinal Cord. 2006 Oct;44(10):625–631.
  • Cao J, Amakye WK, Qi C, et al. Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer’s disease in the APP/PS1 mouse model. Eur J Nutr. 2021Apr;60:1.
  • Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010 May;7(5):335–336.
  • Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016 Jul;13(7):581–583.
  • Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011 Jun 24;12(6):R60.
  • Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013 Sep;31(9):814–821.
  • Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353–D361.
  • Bolyen E, Rideout JR, Dillon MR, et al. Author Correction: reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019 Sep;37(9):1091.
  • Douglas GM, Maffei VJ, Zaneveld J, et al. PICRUSt2: an improved and extensible approach for metagenome inference. 2019. bioRxiv.
  • Zhang C, Jing Y, Zhang W, et al. Dysbiosis of gut microbiota is associated with serum lipid profiles in male patients with chronic traumatic cervical spinal cord injury. Am J Transl Res. 2019;11(8):4817–4834.
  • Binda C, Lopetuso LR, Rizzatti G, et al. Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig Liver Dis. 2018 May;50(5):421–428.
  • Hugenholtz P, Hooper SD, Kyrpides NC. Focus: synergistetes. Environ Microbiol. 2009 Jun;11(6):1327–1329.
  • Myers SA, Gobejishvili L, Saraswat Ohri S, et al. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiol Dis. 2019 Apr;124:353–363.
  • Marchandin H, Damay A, Roudière L, et al. Phylogeny, diversity and host specialization in the phylum Synergistetes with emphasis on strains and clones of human origin. Res Microbiol. 2010;161(2):91–100.
  • Yu XL, Chan Y, Zhuang LF, et al. Distributions of Synergistetes in clinically-healthy and diseased periodontal and peri-implant niches. Microb Pathog. 2016;94:90–103.
  • Nuli R, Cai J, Kadeer A, et al. Integrative analysis toward different glucose tolerance-related gut microbiota and diet. Front Endocrinol (Lausanne). 2019;10:295.
  • Olivia Gilbert, James R, Croffoot Allen; J. Taylor, Mark Nash. Serum lipid concentrations among persons with spinal cord injury – a systematic review and meta-analysis of the literature. Atherosclerosis. 2014.
  • Brewer KL, Hardin JS. Neuroprotective effects of nicotinamide after experimental spinal cord injury. Acad Emerg Med. 2004 Feb;11(2):125–130.
  • Seelig J, Heller RA, Hackler J, et al. Selenium and copper status - potential signposts for neurological remission after traumatic spinal cord injury. J Trace Elem Med Biol org Soc Min Trace Elem (GMS). 2020 Jan 57:126415. .
  • Heller RA, Seelig J, Bock T, et al. Relation of selenium status to neuro-regeneration after traumatic spinal cord injury. J Trace Elem Med Biol org Soc Min Trace Elem (GMS). 2019 Jan 51:141–149. .
  • Linares DM, Ross P, Stanton C. Beneficial Microbes: the pharmacy in the gut. Bioengineered. 2016;7(1):11–20.
  • Roediger WE. Short chain fatty acids as metabolic regulators of ion absorption in the colon. Acta veterinaria Scandinavica Supplementum. 1989;86:116–125.
  • Scaldaferri F, Pizzoferrato M, Gerardi V, et al. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012 Oct;46(Suppl):S12–17.
  • Zhao X, Zhang Z, Hu B, et al. Response of gut microbiota to metabolite changes induced by endurance exercise. Front Microbiol. 2018;9:765.
  • Guida F, Boccella S, Belardo C, et al. Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain. Brain Behav Immun. 2020 Mar;85:128–141.
  • Lax NC, Ahmed KT, Ignatz CM, et al. Marine cyanobacteria-derived serotonin receptor 2C active fraction induces psychoactive behavioral effects in mice. Pharm Biol. 2016 Nov;54(11):2723–2731.
  • Lopez-Siles M, Duncan SH, Garcia-Gil LJ, et al. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. Isme J. 2017;11(4):841.
  • Nagy-Szakal D, Williams BL, Mishra N, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome, 2017;5(1): 44..